Q2 2025 13F Holders as of 6/30/2025
-
Type / Class
-
Equity / Common Stock, $0.01 par value
-
Shares outstanding
-
127M
-
Number of holders
-
113
-
Total 13F shares, excl. options
-
69.4M
-
Shares change
-
+4.96M
-
Total reported value, excl. options
-
$254M
-
Value change
-
+$15.2M
-
Put/Call ratio
-
0
-
Number of buys
-
51
-
Number of sells
-
-87
-
Price
-
$3.66
Significant Holders of Organogenesis Holdings Inc. - Common Stock, $0.01 par value (ORGO) as of Q2 2025
156 filings reported holding ORGO - Organogenesis Holdings Inc. - Common Stock, $0.01 par value as of Q2 2025.
Organogenesis Holdings Inc. - Common Stock, $0.01 par value (ORGO) has 113 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 69.4M shares
of 127M outstanding shares and own 54.69% of the company stock.
Largest 10 shareholders include Soleus Capital Management, L.P. (12.3M shares), MORGAN STANLEY (12.1M shares), First Light Asset Management, LLC (6.78M shares), VANGUARD GROUP INC (5.2M shares), BlackRock, Inc. (4.73M shares), DEUTSCHE BANK AG\ (3.28M shares), DIMENSIONAL FUND ADVISORS LP (3.1M shares), Assenagon Asset Management S.A. (2.86M shares), ACADIAN ASSET MANAGEMENT LLC (2.42M shares), and GEODE CAPITAL MANAGEMENT, LLC (1.67M shares).
This table shows the top 113 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.